| # | Drug | Count |
|---|---|---|
| 0 | CYCLOSPORINE | 125 |
| 1 | METHOTREXATE SODIUM | 112 |
| 2 | METHOTREXATE | 108 |
| 3 | CYCLOPHOSPHAMIDE | 101 |
| 4 | CYCLOPHOSPHAMIDE FOR INJECTION | 101 |
| 5 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 101 |
| 6 | BEVACIZUMAB | 94 |
| 7 | PREDNISOLONE | 78 |
| 8 | PREDNISOLONE ORAL | 78 |
| 9 | PREDNISOLONE ORAL SOLUTION | 78 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | VECURONIUM BROMIDE | 4 | 0.0026 |
| 1 | DEXRAZOXANE FOR INJECTION | 2 | 0.0021 |
| 2 | MEFENAMIC ACID | 4 | 0.0018 |
| 3 | ISOFLURANE | 3 | 0.0015 |
| 4 | HYDROCORTISONE SODIUM SUCCINATE | 6 | 0.0015 |
| 5 | IMIPENEM AND CILASTATIN SODIUM | 3 | 0.0014 |
| 6 | VINCRISTINE SULFATE | 41 | 0.0014 |
| 7 | NICARDIPINE HYDROCHLORIDE | 3 | 0.0013 |
| 8 | DINOPROSTONE | 1 | 0.0012 |
| 9 | DAUNORUBICIN HYDROCHLORIDE | 2 | 0.0012 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 204 |
| 1 | Calcineurin Inhibitor Immunosuppressant [EPC] | 125 |
| 2 | Alkylating Drug [EPC] | 114 |
| 3 | Folate Analog Metabolic Inhibitor [EPC] | 111 |
| 4 | Platinum-based Drug [EPC] | 108 |
| 5 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 96 |
| 6 | Nucleoside Metabolic Inhibitor [EPC] | 95 |
| 7 | Benzodiazepine [EPC] | 32 |
| 8 | Proton Pump Inhibitor [EPC] | 31 |
| 9 | Nonsteroidal Anti-inflammatory Drug [EPC] | 30 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Calcineurin Inhibitor Immunosuppressant [EPC] | 125 | 0.0010 |
| 1 | Lymphocyte Growth Factor [EPC] | 1 | 0.0008 |
| 2 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 96 | 0.0005 |
| 3 | Cannabinoid [EPC] | 4 | 0.0005 |
| 4 | Alkylating Drug [EPC] | 114 | 0.0005 |
| 5 | Platinum-based Drug [EPC] | 108 | 0.0004 |
| 6 | Osmotic Diuretic [EPC] | 2 | 0.0004 |
| 7 | Nucleoside Metabolic Inhibitor [EPC] | 95 | 0.0003 |
| 8 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 3 | 0.0003 |
| 9 | Topoisomerase Inhibitor [EPC] | 22 | 0.0003 |